Skip to main content

Advertisement

SpringerLink
Log in

Clinical Outcome of Malignant Biliary Obstruction Caused by Metastatic Gastric Cancer

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer remains unclear. This study was designed to evaluate the clinical outcome and predictive factors of survival in patients who underwent percutaneous transhepatic biliary drainage (PTBD) for malignant biliary obstruction caused by metastatic gastric cancer.

Methods

Between April 1997 and March 2006, 38 consecutive patients with malignant biliary obstruction caused by metastatic gastric cancer were retrospectively analyzed. All patients underwent PTBD.

Results

After PTBD, serum bilirubin levels significantly decreased in 29 (76%) of 38 patients. Pruritus, fever, jaundice, anorexia, abdominal pain, and general fatigue improved significantly in 100%, 100%, 78%, 64%, 53%, and 48% of patients, respectively. Early complications related to the intervention occurred in ten patients. Seven patients developed symptoms of recurrent jaundice or cholangitis. Overall median survival was 79 days, and 6-month and 1-year survival rates after PTBD were 39.5% and 13.2%, respectively. Serum bilirubin level after PTBD (P < 0.0001), chemotherapy after PTBD (P < 0.0001), and performance status at presentation (P = 0.0363) were found to be independent predictors of survival.

Conclusion

PTBD with metallic stent placement is a safe and effective palliation for patients with malignant biliary obstruction caused by metastatic gastric cancer. Our results suggest that patients in good clinical condition are candidates for aggressive treatment with a combination of PTBD with metallic stent placement and chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Papachristou D, Fortner JG (1978) Biliary obstruction after gastrectomy for carcinoma of the stomach. Surg Gynecol Obstet 147:401–404

    PubMed  CAS  Google Scholar 

  2. Lokich JJ, Kane RA, Harrison DA et al (1987) Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol 5:969–981

    PubMed  CAS  Google Scholar 

  3. Anderson ID, Manson JM, Martin DF et al (1993) Relief of metastatic biliary obstruction by stent placement: is it worthwhile? Surg Oncol 2:113–117

    Article  PubMed  CAS  Google Scholar 

  4. Rieber A, Brambs HJ (1997) Metallic stents in malignant biliary obstruction. Cardiovasc Intervent Radiol 20:43–49

    Article  PubMed  CAS  Google Scholar 

  5. Inal M, Akgül E, Aksungur E et al (2003) Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol 44:139–146

    Article  PubMed  CAS  Google Scholar 

  6. Indar AA, Lobo DN, Gilliam AD et al (2003) Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 15:915–919

    Article  PubMed  Google Scholar 

  7. Brountzos EN, Ptochis N, Panagiotou I et al (2007) A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 30:66–73

    Article  PubMed  Google Scholar 

  8. Kim GE, Shin HS, Seong JS et al (1994) The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma. Int J Radiat Oncol Biol Phys 28:711–717

    PubMed  CAS  Google Scholar 

  9. Makino T, Fujitani K, Tsujinaka T et al (2008) Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer. Hepatogastroenterology 55:54–57

    PubMed  Google Scholar 

  10. Chu KM, Law S, Branicki FJ et al (1998) Extrahepatic biliary obstruction by metastatic gastric carcinoma. J Clin Gastroenterol 27:63–66

    Article  PubMed  CAS  Google Scholar 

  11. Lee BH, Chin SY, Kim SA et al (1995) Obstructive jaundice in gastric carcinoma: cause, site, and relationship to the primary lesion. Abdom Imaging 20:307–311

    Article  PubMed  CAS  Google Scholar 

  12. Iwasaki M, Furuse J, Yoshino M et al (1996) Percutaneous transhepatic biliary drainage for the treatment of obstructive jaundice caused by metastases from nonbiliary and nonpancreatic cancers. Jpn J Clin Oncol 26:465–468

    PubMed  CAS  Google Scholar 

  13. Brountzos EN, Petropoulos E, Kelekis NL et al (1999) Malignant biliary obstruction: management with percutaneous metallic stent placement. Hepatogastroenterology 46:2764–2771

    PubMed  CAS  Google Scholar 

  14. van Delden OM, Laméris JS (2008) Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 18:448–456

    Article  PubMed  Google Scholar 

  15. Okamoto T, Yanagisawa S, Fujioka S et al (2006) Is metallic stenting worthwhile for biliary obstruction due to lymph node metastases? J Surg Oncol 94:614–618

    Article  PubMed  Google Scholar 

  16. Kawamoto H, Ishii Y, Nakagawa M et al (2003) Analysis of longterm survivors with expandable metallic stent inserted for malignant biliary stenosis. J Hepatobiliary Pancreat Surg 10:95–100

    PubMed  Google Scholar 

  17. Marsh WH, Cunningham JT (1992) Endoscopic stent placement for obstructive jaundice secondary to metastatic malignancy. Am J Gastroenterol 87:985–990

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Nara Prefectural Nara Hospital, 1-30-1 Hiramatsu, Nara, 631-0846, Japan

    Kazuhiro Migita, Akihiko Watanabe, Shoichi Kinoshita & Takao Ohyama

  2. Department of Radiology, Nara Prefectural Nara Hospital, 1-30-1 Hiramatsu, Nara, 631-0846, Japan

    Tetsuya Yoshioka

Authors
  1. Kazuhiro Migita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akihiko Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetsuya Yoshioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shoichi Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takao Ohyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhiro Migita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Migita, K., Watanabe, A., Yoshioka, T. et al. Clinical Outcome of Malignant Biliary Obstruction Caused by Metastatic Gastric Cancer. World J Surg 33, 2396–2402 (2009). https://doi.org/10.1007/s00268-009-0186-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-0186-0

Keywords

Search

Navigation